ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Afatinib Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7V6133
Home | Market Reports | Health| Pharmacy
Global Afatinib Market Insights and Forecast to 2028
BUY CHAPTERS

Global Afatinib Market Research Report 2025

Code: QYRE-Auto-7V6133
Report
September 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma

Afatinib Market

The global market for Afatinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Afatinib is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Afatinib is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Afatinib in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Afatinib include Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Afatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Afatinib.
The Afatinib market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Afatinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Afatinib companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Afatinib Market Report

Report Metric Details
Report Name Afatinib Market
Segment by Type
  • 30mg Tables
  • 40mg Tables
  • 50mg Tables
  • 25mg Tables
  • 20mg Tables
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Drug Center
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Afatinib company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Afatinib Market report?

Ans: The main players in the Afatinib Market are Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma

What are the Application segmentation covered in the Afatinib Market report?

Ans: The Applications covered in the Afatinib Market report are Hospital, Clinic, Drug Center, Others

What are the Type segmentation covered in the Afatinib Market report?

Ans: The Types covered in the Afatinib Market report are 30mg Tables, 40mg Tables, 50mg Tables, 25mg Tables, 20mg Tables, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Afatinib Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 30mg Tables
1.2.3 40mg Tables
1.2.4 50mg Tables
1.2.5 25mg Tables
1.2.6 20mg Tables
1.2.7 Others
1.3 Market by Application
1.3.1 Global Afatinib Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Afatinib Market Perspective (2020-2031)
2.2 Global Afatinib Growth Trends by Region
2.2.1 Global Afatinib Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Afatinib Historic Market Size by Region (2020-2025)
2.2.3 Afatinib Forecasted Market Size by Region (2026-2031)
2.3 Afatinib Market Dynamics
2.3.1 Afatinib Industry Trends
2.3.2 Afatinib Market Drivers
2.3.3 Afatinib Market Challenges
2.3.4 Afatinib Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Afatinib Players by Revenue
3.1.1 Global Top Afatinib Players by Revenue (2020-2025)
3.1.2 Global Afatinib Revenue Market Share by Players (2020-2025)
3.2 Global Afatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Afatinib Revenue
3.4 Global Afatinib Market Concentration Ratio
3.4.1 Global Afatinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Afatinib Revenue in 2024
3.5 Global Key Players of Afatinib Head office and Area Served
3.6 Global Key Players of Afatinib, Product and Application
3.7 Global Key Players of Afatinib, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Afatinib Breakdown Data by Type
4.1 Global Afatinib Historic Market Size by Type (2020-2025)
4.2 Global Afatinib Forecasted Market Size by Type (2026-2031)
5 Afatinib Breakdown Data by Application
5.1 Global Afatinib Historic Market Size by Application (2020-2025)
5.2 Global Afatinib Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Afatinib Market Size (2020-2031)
6.2 North America Afatinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Afatinib Market Size by Country (2020-2025)
6.4 North America Afatinib Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Afatinib Market Size (2020-2031)
7.2 Europe Afatinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Afatinib Market Size by Country (2020-2025)
7.4 Europe Afatinib Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Afatinib Market Size (2020-2031)
8.2 Asia-Pacific Afatinib Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Afatinib Market Size by Region (2020-2025)
8.4 Asia-Pacific Afatinib Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Afatinib Market Size (2020-2031)
9.2 Latin America Afatinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Afatinib Market Size by Country (2020-2025)
9.4 Latin America Afatinib Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Afatinib Market Size (2020-2031)
10.2 Middle East & Africa Afatinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Afatinib Market Size by Country (2020-2025)
10.4 Middle East & Africa Afatinib Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Afatinib Introduction
11.1.4 Boehringer Ingelheim Revenue in Afatinib Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Hengrui Medicine
11.2.1 Hengrui Medicine Company Details
11.2.2 Hengrui Medicine Business Overview
11.2.3 Hengrui Medicine Afatinib Introduction
11.2.4 Hengrui Medicine Revenue in Afatinib Business (2020-2025)
11.2.5 Hengrui Medicine Recent Development
11.3 Beacon Pharma
11.3.1 Beacon Pharma Company Details
11.3.2 Beacon Pharma Business Overview
11.3.3 Beacon Pharma Afatinib Introduction
11.3.4 Beacon Pharma Revenue in Afatinib Business (2020-2025)
11.3.5 Beacon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
List of Tables
 Table 1. Global Afatinib Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 30mg Tables
 Table 3. Key Players of 40mg Tables
 Table 4. Key Players of 50mg Tables
 Table 5. Key Players of 25mg Tables
 Table 6. Key Players of 20mg Tables
 Table 7. Key Players of Others
 Table 8. Global Afatinib Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Afatinib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Afatinib Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Afatinib Market Share by Region (2020-2025)
 Table 12. Global Afatinib Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Afatinib Market Share by Region (2026-2031)
 Table 14. Afatinib Market Trends
 Table 15. Afatinib Market Drivers
 Table 16. Afatinib Market Challenges
 Table 17. Afatinib Market Restraints
 Table 18. Global Afatinib Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Afatinib Market Share by Players (2020-2025)
 Table 20. Global Top Afatinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afatinib as of 2024)
 Table 21. Ranking of Global Top Afatinib Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Afatinib Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Afatinib, Headquarters and Area Served
 Table 24. Global Key Players of Afatinib, Product and Application
 Table 25. Global Key Players of Afatinib, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Afatinib Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Afatinib Revenue Market Share by Type (2020-2025)
 Table 29. Global Afatinib Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Afatinib Revenue Market Share by Type (2026-2031)
 Table 31. Global Afatinib Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Afatinib Revenue Market Share by Application (2020-2025)
 Table 33. Global Afatinib Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Afatinib Revenue Market Share by Application (2026-2031)
 Table 35. North America Afatinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Afatinib Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Afatinib Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Afatinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Afatinib Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Afatinib Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Afatinib Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Afatinib Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Afatinib Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Afatinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Afatinib Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Afatinib Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Afatinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Afatinib Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Afatinib Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Boehringer Ingelheim Company Details
 Table 51. Boehringer Ingelheim Business Overview
 Table 52. Boehringer Ingelheim Afatinib Product
 Table 53. Boehringer Ingelheim Revenue in Afatinib Business (2020-2025) & (US$ Million)
 Table 54. Boehringer Ingelheim Recent Development
 Table 55. Hengrui Medicine Company Details
 Table 56. Hengrui Medicine Business Overview
 Table 57. Hengrui Medicine Afatinib Product
 Table 58. Hengrui Medicine Revenue in Afatinib Business (2020-2025) & (US$ Million)
 Table 59. Hengrui Medicine Recent Development
 Table 60. Beacon Pharma Company Details
 Table 61. Beacon Pharma Business Overview
 Table 62. Beacon Pharma Afatinib Product
 Table 63. Beacon Pharma Revenue in Afatinib Business (2020-2025) & (US$ Million)
 Table 64. Beacon Pharma Recent Development
 Table 65. Research Programs/Design for This Report
 Table 66. Key Data Information from Secondary Sources
 Table 67. Key Data Information from Primary Sources
 Table 68. Authors List of This Report


List of Figures
 Figure 1. Afatinib Picture
 Figure 2. Global Afatinib Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Afatinib Market Share by Type: 2024 VS 2031
 Figure 4. 30mg Tables Features
 Figure 5. 40mg Tables Features
 Figure 6. 50mg Tables Features
 Figure 7. 25mg Tables Features
 Figure 8. 20mg Tables Features
 Figure 9. Others Features
 Figure 10. Global Afatinib Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Afatinib Market Share by Application: 2024 VS 2031
 Figure 12. Hospital Case Studies
 Figure 13. Clinic Case Studies
 Figure 14. Drug Center Case Studies
 Figure 15. Others Case Studies
 Figure 16. Afatinib Report Years Considered
 Figure 17. Global Afatinib Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Afatinib Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Afatinib Market Share by Region: 2024 VS 2031
 Figure 20. Global Afatinib Market Share by Players in 2024
 Figure 21. Global Top Afatinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afatinib as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Afatinib Revenue in 2024
 Figure 23. North America Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Afatinib Market Share by Country (2020-2031)
 Figure 25. United States Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Afatinib Market Share by Country (2020-2031)
 Figure 29. Germany Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Afatinib Market Share by Region (2020-2031)
 Figure 37. China Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Afatinib Market Share by Country (2020-2031)
 Figure 45. Mexico Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Afatinib Market Share by Country (2020-2031)
 Figure 49. Turkey Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Afatinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Boehringer Ingelheim Revenue Growth Rate in Afatinib Business (2020-2025)
 Figure 53. Hengrui Medicine Revenue Growth Rate in Afatinib Business (2020-2025)
 Figure 54. Beacon Pharma Revenue Growth Rate in Afatinib Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Apatinib Market Research Report 2024
Global Alectinib Market Research Report 2024
Global Gefitinib Market Research Report 2024
Global Afatinib Maleate Tablets Market Research Report 2024
Global Lorlatinib Market Research Report 2024
Global Fostamatinib Market Research Report 2024
Global Crizotinib Market Research Report 2024
Global Anlotinib Market Research Report 2024
Global Ibrutinib Market Research Report 2024
Global Neratinib Market Research Report 2024
Imatinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ruxolitinib Market Research Report 2024
Global Erlotinib Market Research Report 2024
Gefitinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Afamelanotide Market Research Report 2024
Global Ceritinib Market Research Report 2024
Global Tucatinib Market Research Report 2025
Global Imatinib Mesylate Market Research Report 2024
Global Axitinib Market Research Report 2025
Global Tyrosine Kinase Inhibitor Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions